This association suggests that immune-evasive mechanisms involving HLA-G may be more prominent in genomically aggressive disease, and that EV-associated checkpoints could serve as both functional and molecular markers of high-risk MM. The gene discussed is HLA-G; the disease is Miyoshi myopathy.